Dozens of Axon employees rallied outside the state capitol, urging lawmakers to move forward with two proposed bills designed ...

These itemized elaborations have been created using the accompanying table. - Call Contracts: The right to buy shares as indicated in the contract. - Put Contracts: The right to sell shares as ...

Groundbreaking research from the University of Kentucky has earned a spot on the cover of the prestigious Journal of ...

The biological and neurological ability of BDNF to cross the blood-brain barrier and the application of new and novel ...

Quantification of mean axon length (H, I) indicates that transfection of siMLCK inhibits adult DRG neuronal axon growth. Scale bar: 100μm. (N=3, *** p < 0.001). (J, K) L4/L5 DRGs of adult mice were ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...

AXON ANNOUNCES PRICING OF UPSIZED OFFERING OF $1,000.0 MILLION ... Puma Biotechnology, Inc. , a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President ...

Real-time index price for TSX Composite Low Volatility (TXLV), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

You need to be a subscriber to view this content.

Highlights,Stock Decline:,Axon’s shares dropped 24% over two days, marking its worst performance since March 2009.,Partnership Tensions:,Analysts cite a fallout between Axon and Flock Safety as a ...